Liu Nanxi 4
4 · Kindred Biosciences, Inc. · Filed Aug 30, 2021
Insider Transaction Report
Form 4
Liu Nanxi
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2021-08-27$4.17/sh−48,000$200,160→ 0 totalExercise: $5.08Exp: 2031-02-04→ Common Stock (48,000 underlying)
Footnotes (1)
- [F1]This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement"), the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $200,160.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.